suPARnostic® Product Line

Worldwide infectious diseases claim more than 17 million deaths every year, with the most frequent causes of death being sepsis/SIRS, tuberculosis and HIV. In the US alone more than 700.000 patients per year fall ill with sepsis/SIRS, about 200.000 of them die from the condition. Not to mention the death toll by those diseases in the developing world.

With development of the suPARnostic® marker ViroGates has succeeded in taking an important step towards global health monitoring. suPARnostic® is a prognostic tool which allows early detection of a critical disease state in the body - with such knowledge life-saving intervention could be initiated earlier and monitored for success.

ViroGates focus is to make the suPARnostic® parameter available in various test formats, suitable for the different areas of healthcare management.

Our current products are:

A001 - suPARnostic® Standard: ELISA test kit for research and large trials

A002 - suPARnostic® Flex: ELISA test kit for clinical testing

A003 - suPARnostic® Quick Triage - Point of Care Test Device for early Warning and Intervention

A004 - suPARnostic® Quick Test Reader



Please visit our product page on www.suparnostic.com for more information about our products

 

ViroGates A/S

pears.jpg

Meet Us

We are routinely participating in international partnering and sales conferences.

For further details please visit www.suparnostic.com or call us at +45 3698 0645.


News

Latest Article:

"ViroGates - Measuring blood in the health care sector in Kenya..."                

 

"Dansk opfindelse kan fange sygdomssignaler i opløbet...."                                                                              

 

Latest Press Releases:

ViroGates launches suPARnostic® Quick Triage product....                                                                                 

 

ViroGates receives product approval in Canada
and enters into distribution agreement with Cedarlane....